Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
P. Bradley, J. Herre, S. Marciniak, J. Wason, P. Sivasothy (Cambridge, United Kingdom). Evaluating the utility of mesothelin in diagnosing mesothelioma. Eur Respir J 2013; 42: Suppl. 57, 2937

Member's Comments

No comment yet.

Related content which might interest you: Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Association of biochemical determinants and fibrinous formation in malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Role of Dr-70 immunoassay in suspected malignant pleural effusion Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Role of fibulin-3 in the diagnosis of malignant mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions? Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 1,25-dihydroxyvitamin D in malignant and non-malignant pleural effusions Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Malignant mesothelioma diagnosed at medical thoracoscopy – A service review Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 Diagnostic values of inflammation biomarkers in pleural effusions (PE) Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Prognostic impact of histology and treatment modalities in malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Diagnostic impact of EUS(b)-FNA in diagnostics of sarcoidosis Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy Year: 2013 Predictive value of pro-inflammatory cytokine and pro-angiogenic factor in differentiating malignant from benign exudative effusion Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Haematologic parameters and their prognostic impact in malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Pleural mesothelioma with solitary simultaneous subcutaneous tissue metastasis of the abdominal wall at diagnosis - First clinical documentation Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 Role of tumor derived versican in experimental malignant pleural mesothelioma Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016 Biological markers of successful pleurodesis for malignant pleural effusion Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016 Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014